Sorry, you need to enable JavaScript to visit this website.

Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.

The DiRECT-Aus Trial - Clinical Paper Summary - New Research

The Direct AUS Trial T2D & VLED

Learn about new Australian clinical evidence on the impact of the very low energy diets for Type 2 Diabetes remission.

The DiRECT-Aus trial confirms that that an intensive lifestyle intervention (very low energy diet) delivered in an Australian primary care setting to individuals with recently diagnosed type 2 diabetes results in remission for one in two participants.
The study was supported by Diabetes Australia (not-for-profit organisation), and 5 public health networks. Nestlé Health Science donated OPTIFAST VLCD product for the duration of the trial.

Click here to view the video.